Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus.
about
Viral Infection in the Development and Progression of Pediatric Acute Respiratory Distress SyndromeNeutralizing antibody response and SARS severityDifferences in viral load among human respiratory syncytial virus genotypes in hospitalized children with severe acute respiratory infections in the Philippines.Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P.Duration of shedding of respiratory syncytial virus in a community study of Kenyan childrenA systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection.Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults.Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.Viral load drives disease in humans experimentally infected with respiratory syncytial virusProtection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.LDH concentration in nasal-wash fluid as a biochemical predictor of bronchiolitis severity.TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarizationAn overview of respiratory syncytial virus.Current treatment for acute viral bronchiolitis in infants.Progress in understanding and controlling respiratory syncytial virus: still crazy after all these yearsRespiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trialsRespiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and FinlandComparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus sheddingHigh pneumococcal density correlates with more mucosal inflammation and reduced respiratory syncytial virus disease severity in infantsRespiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.Epidemiology and Clinical Presentations of Respiratory Syncytial Virus Subgroups A and B Detected with Multiplex Real-Time PCRCharacteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of AgeThe interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitisViral and host factors in human respiratory syncytial virus pathogenesis.The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection.Antibody response to respiratory syncytial virus infection in children <18 months oldGene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis.The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.Respiratory syncytial virus: current progress in vaccine development.Respiratory syncytial virus--a comprehensive review.Consolidation of molecular testing in clinical virology.Etiology and clinical features of viral bronchiolitis in infancy.Epidemiology and clinical presentation of respiratory syncytial virus infection in a Tunisian neonatal unit from 2000 to 2002.Clinical characteristics and viral load of respiratory syncytial virus and human metapneumovirus in children hospitaled for acute lower respiratory tract infection.Respiratory syncytial virus shedding by children hospitalized with lower respiratory tract infection.Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium.Molecular quantification of respiratory syncytial virus in respiratory samples: reliable detection during the initial phase of infectionAssociation of the CT values of real-time PCR of viral upper respiratory tract infection with clinical severity, Kenya.Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus.
P2860
Q28071857-0675568B-0211-4E96-B396-B100E47641B3Q28385241-F87B89E1-6C44-4EDD-9399-EA2A975615A8Q30383135-35057925-BA10-4AF1-8E93-C6A0FDAE97B5Q33302897-EC627487-3766-426C-97E0-00C9A7F26299Q33526047-FCE57653-8B17-43E6-8D86-3919AB8D6DBEQ33648976-ED57F162-D9CC-4B06-A83C-20F28AB6EDE4Q33809443-6FD096F6-19D7-40F3-8D9B-130DAAE180F3Q33961412-5C4D04AE-BC17-4CCA-BA9E-98635328941BQ34224973-C2CA593B-491B-4C35-8E71-D60461546144Q34402459-8E6C61D1-EE87-4D1D-8244-3EF18858F1E7Q34542687-0C166C13-17E5-4E95-9A2C-855F1988BA97Q34630095-AAEC7DD5-FED4-4F92-AA2F-A67F48413E3BQ35056722-60C8C593-94A5-46A9-8603-8C7A43A05092Q35157041-34BE0672-842E-4775-AD8B-6312685A27A4Q35183760-09DAA125-6F84-4939-A231-D6846EB2620CQ35566601-0AD38814-A65B-4990-98CB-3F6797ABC297Q35761061-19A9D639-4A9D-4546-9740-918FB9D38C9CQ35784613-C5F12F7F-B22F-427A-9CC1-3EBB8B8D177EQ35922051-642C372B-9C70-429C-94DC-168D40A46D66Q35959972-84649418-7A64-4266-BF81-D21F274B0CA0Q35989482-F91264D1-6EE3-4CAE-9D8A-CA9393EC337EQ36169484-9E3D3EBB-B9EA-4DFE-8179-C130162386C0Q36263882-5BF23DA3-BA79-4BC8-9B42-2A63CA91CD87Q36299483-3B57238B-5852-43FD-BF47-F71F5FD2D64BQ36483836-8BBBE08F-D216-4B33-B563-E50966031138Q37123113-096731F7-8417-43CC-B2DE-CBCB5DB2146CQ37135395-D32ADD21-F018-4EFA-B2C1-B320B2AB21E4Q37213863-464E370A-E302-4BCD-B582-4B532BC3C8F1Q37384009-34FDFE37-3D34-4D45-B6DA-D587F4F039F9Q38079432-DCF20BB2-F1CF-4857-90F1-B9DF503B95D9Q38098094-B0E8AA4F-4E22-4B54-8A58-7230E40B7362Q38779627-068879C0-DD02-42D9-956D-97AE126EBCB1Q38805610-9742769E-2C34-4F33-ACCF-5EF3F984B70DQ39007049-03EFBA82-9737-4F4F-B517-80538059A988Q40088626-440FD86E-0D84-43A2-9645-9D1B1F6C050FQ40902098-54E14BC2-75FC-4F64-85AF-5C41237FD1A6Q42276206-07FF2642-32F7-433D-A70F-569EBA6163B9Q42411056-11936D5E-F3E7-426B-A967-2045F7A7552BQ44006155-5EA7C5A6-E344-43F4-9A09-767C5AD36FFFQ45264827-152C30AE-E71E-4432-B4D3-FBD9CF8315F2
P2860
Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Illness severity, viral sheddi ...... y respiratory syncytial virus.
@en
Illness severity, viral sheddi ...... y respiratory syncytial virus.
@nl
type
label
Illness severity, viral sheddi ...... y respiratory syncytial virus.
@en
Illness severity, viral sheddi ...... y respiratory syncytial virus.
@nl
prefLabel
Illness severity, viral sheddi ...... y respiratory syncytial virus.
@en
Illness severity, viral sheddi ...... y respiratory syncytial virus.
@nl
P2093
P921
P356
P1476
Illness severity, viral sheddi ...... y respiratory syncytial virus.
@en
P2093
Frances Robinson
George Reed
Melissa Peters
Peter F Wright
Shanita Coleman-Dockery
William C Gruber
P304
P356
10.1086/339822
P407
P577
2002-04-01T00:00:00Z